Note 20 - Share-based Compensation Expenses

9 Months Ended

Sep. 30, 2025

Notes to Financial Statements

Share-Based Payment Arrangement [Text Block]

20. Share-based compensation expenses

In August 2024, the Company granted and issued approximately 0.18 million fully-vested and non-forfeitable shares of the Company restricted common stock to business and financial consultants in exchange for their service for a 12-month period until August 2025. The Company valued these shares at the closing bid price of the Company’s common stock on the grant date of these shares and recorded the related total cost of approximately US$0.35 million as a prepayment upon the grant and issuance of these shares. Total compensation expenses amortized was approximately US$0.35 million and US$0.06 million for the nine and three months ended September 30, 2025.

The table below summarized share-based compensation expenses recorded for the nine and three months ended September 30, 2025 and 2024, respectively:

	Nine Months Ended September 30,				Three Months Ended September 30,
	2025		2024		2025		2024
	US$(’000)		US$(’000)		US$(’000)		US$(’000)
	(Unaudited)		(Unaudited)		(Unaudited)		(Unaudited)
Sales and marketing expenses		-		-		-		-
General and administrative expenses		346		1,642		59		1,642
Research and development expenses		-		-		-		-
Total		346		1,642		59		1,642